Evgen Pharma plc announced a private placement for the gross proceeds of $17,400,000 on January 16, 2024. The transaction included participation from new investor Stalicla SA.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 GBX | 0.00% | -6.25% | -53.12% |
Apr. 26 | Evgen Pharma plc will Change its Ticker to TCF from EVG | CI |
Apr. 26 | Evgen Pharma plc will Change its Name to TheraCryf plc | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.12% | 4M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- EVG Stock
- News Theracryf Plc
- Evgen Pharma plc announced that it has received $17.4 million in funding from Stalicla SA